Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Monolithic Power Systems Inc (MPWR) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Monolithic Power Systems IncTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Monolithic Power Systems Inc vs Zimmer Biomet Holdings Inc — how do they compare? Monolithic Power Systems Inc trades at $1,197.1 (market cap $59.88B), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $17.97B). The key difference: Monolithic Power Systems Inc is far larger — about 3.3× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.02%). Which is the better fit depends on your goals.

MPWRZBH
Market Cap
$59.88B$17.97B
Sector
UtilitiesHealth
52-Week High
$1.69K$104.26
52-Week Low
$834.14$79.58
Enterprise Value
$58.49B$25.04B
Dividend Yield
0.66%1.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Monolithic Power Systems Inc

MPWR trades at $1,218.50, down 0.44% on the day, with technical indicators showing bearish momentum despite recent earnings beats. The company reported strong Q2 2026 results with EPS of $6.50 beating expectations of $5.87, driven by AI infrastructure demand. Valuation remains elevated with a P/E of 74.34 and P/S of 18.21, while profitability metrics show robust net income margin of 24.5% and ROE of 21.98%.

The stock faces near-term technical pressure but maintains strong fundamental growth prospects from AI and server demand. Analyst consensus remains overwhelmingly bullish with 88% buy ratings and a $1,860 price target representing 53% upside. Key risks include premium valuation concerns and potential double-ordering in enterprise data segments.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $94.22, down 3.93% on the day, with a bearish technical signal but strong fundamentals including a 69.87% gross margin and three consecutive quarterly earnings beats. Revenue growth is steady, reaching $8.23B in 2025, though net income margin dipped to 8.56%. Recent leadership promotions aim to accelerate commercial transformation, while analyst consensus price target is $104.88, implying 11.3% upside.

The stock presents a value opportunity with a P/E of 22.87 and P/S of 2.17, supported by robust cash flow and dividend payments. Risks include rising debt-to-asset ratio (32.57% in 2025) and competitive pressures. Wall Street sentiment is mixed with 40.48% buy ratings, but technical indicators suggest near-term caution amid bearish moving averages.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Monolithic Power Systems Inc

Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.

Read more on MPWR

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH